Bmseed LLC
Tempe, AZ
- UEI
- NS86CTFW6J47
- CAGE
- 6UXS8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1440 E Northshore Dr, Tempe, AZ 85283, USA
- Website
- bmseed.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Microelectrode array stretching stimulating UND recording equipment(meassure)system with parts and training | ACC Aberdeen Proving Ground | $124,460 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Synapticure Inc. | Kenilworth, IL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Modendo Inc. | Boulder, CO | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Stem Pharmacy | Fitchburg, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| 28Bio, Inc. | Metairie, LA | 541380 Testing Laboratories and Services |
| Alcorix CO. | Plainfield, IL | 541713 Research and Development in Nanotechnology |
About the company
Bmseed LLC is a manufacturer of research equipment that replicates in vitro, stretch induced neurotrauma for high content screening of treatment therapies and injury mechanisms in academic research and pharmaceutical settings. The company is registered as a corporate entity and for-profit organization in the System for Award Management (SAM.gov).
Bmseed LLC has been awarded several federal grants from the National Institutes of Health to develop novel research platforms and equipment. In 2022, the company received a $1.76 million grant from the National Institute on Aging to commercialize a microfluidic chip-based platform for modeling Alzheimer's disease and related dementias. This platform, integrating stretchable microelectrodes, aims to provide an efficient and physiologically relevant pre-clinical drug screening tool for Alzheimer's treatments. Additionally, in 2021, Bmseed LLC was awarded a $1.84 million grant from the National Institute of Neurological Disorders and Stroke to develop the Organoid-Based Stimulating und Recording Vacuum Equipment (OBSURVE) platform. This platform, featuring a conformable multi-dimensional electrode array, is designed to enhance brain organoid models for preclinical drug screening and disease modeling of neurological and neurodegenerative conditions. The company has also received a sub-award from Boston University, where Bmseed's electrodes will be fabricated and integrated into a nanoclip device.
SBA capabilities narrative
BMSEED provides research equipment for neurotrauma research (traumatic brain injury, concussions, spinal cord injury) and tissue engineering researchers
Quick answers
Is Bmseed LLC registered in SAM.gov?
Yes. Bmseed LLC's SAM.gov registration is active through February 6, 2027.
What is Bmseed LLC's most recent federal award?
Bmseed LLC's most recent federal grant award is A physiologically relevant pre-clinical drug screening platform for alzheimer's disease and traumatic brain injury with… (R44AG079777), from National Institute on Aging (NIH), on September 30, 2022.
On GovTribe
See Bmseed LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors